References
Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE (2004) Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65:1416–1421
Mangge H, Liebmann P, Tanil H, Herrmann J, Wagner C, Gallistl S, Schauenstein K, Erwa W (2000) Cystatin C, an early indicator for incipience renal diseases in rheumatoid arthritis. Clin Chim Acta 300:195–202
Risch L, Herklotz R, Blumberg A, Huber AR (2001) Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 47:2055–2059
Karstila K, Harmoinen APT, Lehtimäki TJ, Korpela MM, Mustonen JT, Saha HHT (2008) Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus Cr-EDTA Clearance. Nephron Clin Pract 108:284–290
Bokarewa M, Abrahamson M, Levshin N, Egesten A, Grubb A, Dahlberg L, Tarkowski A (2007) Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties. J Rheumatol 34:1293–1301
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kopec-Medrek, M., Widuchowska, M., Kotulska, A. et al. Serum cystatin C level in patients with rheumatoid arthritis after single infusion of infliximab. Rheumatol Int 31, 1255–1256 (2011). https://doi.org/10.1007/s00296-010-1572-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1572-5